These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35089377)

  • 1. Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection.
    Khandelwal P; Krishnasamy S; Govindarajan S; Kumar M; Marik B; Sinha A; Hari P; Bagga A
    Pediatr Nephrol; 2022 Sep; 37(9):2151-2156. PubMed ID: 35089377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
    Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
    Front Immunol; 2019; 10():1282. PubMed ID: 31231391
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Factor H Antibody-Associated Atypical Hemolytic Uremic Syndrome: A Case Report.
    Abazi-Emini N; Sahpazova E; Putnik J; Tasic V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct; 42(2):109-115. PubMed ID: 34699711
    [No Abstract]   [Full Text] [Related]  

  • 4. Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome.
    Thangaraju S; Khandelwal P; Mishra K; Kumar M; Puraswani M; Saini R; Hari P; Coshic P; Sinha A; Bagga A
    Pediatr Nephrol; 2024 Jul; 39(7):2091-2097. PubMed ID: 38270601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-factor B antibodies in atypical hemolytic uremic syndrome.
    Khandelwal P; Nambiar S; Saini R; Saini S; Coshic P; Sinha A; Hari P; Palanichamy JK; Bagga A
    Pediatr Nephrol; 2024 Jun; 39(6):1909-1916. PubMed ID: 38252289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma pneumoniae Infection Associated with Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome.
    Valoti E; Piras R; Mele C; Alberti M; Liguori L; Breno M; Bertulli C; Bresin E; Donadelli R
    Nephron; 2022; 146(6):593-598. PubMed ID: 35405682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome.
    Khandelwal P; Joshi A; Mathur A; Puraswani M; Gurjar BS; Sinha A; Hari P; Faruq M; Bagga A
    Pediatr Nephrol; 2023 Aug; 38(8):2659-2668. PubMed ID: 36622444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
    Cugno M; Berra S; Depetri F; Tedeschi S; Griffini S; Grovetti E; Caccia S; Cresseri D; Messa P; Testa S; Giglio F; Peyvandi F; Ardissino G
    J Am Soc Nephrol; 2021 May; 32(5):1227-1235. PubMed ID: 33712527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A; Zipfel PF; Bokarewa MI; Sturfelt G; Jönsen A; Nilsson SC; Hillarp A; Saxne T; Trouw LA; Blom AM
    Arthritis Res Ther; 2012 Aug; 14(4):R185. PubMed ID: 22894814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
    Nozal P; Bernabéu-Herrero ME; Uzonyi B; Szilágyi Á; Hyvärinen S; Prohászka Z; Jokiranta TS; Sánchez-Corral P; López-Trascasa M; Józsi M
    Mol Immunol; 2016 Feb; 70():47-55. PubMed ID: 26703217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
    Rysava R; Peiskerova M; Tesar V; Benes J; Kment M; Szilágyi Á; Csuka D; Prohászka Z
    Front Immunol; 2022; 13():1001366. PubMed ID: 36275662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome.
    Jiang H; Fan MN; Yang M; Lu C; Zhang M; Liu XH; Ma L
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27929404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases.
    Smarz-Widelska I; Syroka-Główka M; Janowska-Jaremek J; Kozioł MM; Załuska W
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].
    Suzuki K; Nagaharu K; Hachiya K; Nishimura K; Matsumoto T; Tawara I
    Rinsho Ketsueki; 2022; 63(3):224-228. PubMed ID: 35387937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.